MarketPeel
Insider Trading Intelligence
DL

Daniel Lesueur

HCAT
CHIEF OPERATING OFFICER · HEALTH CATALYST, INC. · CIK 0002013388
FILING MIX · LIFETIME14%/86%
BUYS
3
SELLS
19
TOTAL VALUE
$863.5K
COMPANIES
1
ACTIVE SINCE
Mar 2024
HOLDINGS NOW
198,367
AVG SELL PX
$6.37
TRADE KIND
SHOWING 22 / 22
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
12 backtested trades · 8 horizons · 10 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Daniel Lesueur, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d12+50.00%-0.38%+0.54%-0.92%+1.34%
14d12+66.67%+0.01%+1.53%-1.52%-5.00%
30d12+50.00%-2.58%+0.84%-3.42%-3.19%
60d12+66.67%-6.14%+1.74%-7.88%-7.43%
90d12+66.67%-8.65%+3.16%-11.81%-15.64%
180d12+83.33%-26.31%+8.84%-35.15%-42.91%
1y12+100.00%-56.29%+18.04%-74.33%-77.97%
2y12(10 pending)+100.00%-69.32%+37.37%-106.69%-106.69%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HCAT · 198,367 shares · as of Sep 2, 2025
060,596121,192181,788242,3842025SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2024
2024
2024
2024
2025
2025
2025
FLOW · 3 buys / 19 sellsCOVERAGE · 7 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HCAT
HEALTH CATALYST, INC.
SALE
Chief Operating Officer
3,663$3.36$12.3K198,367Sep 2, 2025Sep 4, 2025View →
HCAT
HEALTH CATALYST, INC.
SALE
Chief Operating Officer
3,802$3.63$13.8K202,030Jun 2, 2025Jun 3, 2025View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
5,209$4.10$21.3K205,832May 5, 2025May 7, 2025View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
5,209$4.15$21.6K211,041Apr 3, 2025Apr 7, 2025View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
16,902$4.52$76.3K216,250Mar 5, 2025Mar 10, 2025View →
HCAT
HEALTH CATALYST, INC.
SALE
Chief Operating Officer
9,232$4.58$42.3K233,152Mar 3, 2025Mar 4, 2025View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
11,340242,384Feb 20, 2025Feb 24, 2025View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
145,000231,044Feb 20, 2025Feb 24, 2025View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
5,209$5.76$30.0K86,044Feb 5, 2025Feb 6, 2025View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
5,209$7.51$39.1K91,253Jan 6, 2025Jan 8, 2025View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
22,773$7.70$175.2K96,462Dec 4, 2024Dec 6, 2024View →
HCAT
HEALTH CATALYST, INC.
SALE
Chief Operating Officer
10,455$8.97$93.8K119,235Dec 1, 2024Dec 3, 2024View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
5,209$7.70$40.1K129,690Nov 5, 2024Nov 7, 2024View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
5,209$7.68$40.0K134,899Oct 3, 2024Oct 8, 2024View →
HCAT
HEALTH CATALYST, INC.
SALE
Chief Operating Officer
8,137$7.58$61.7K140,108Sep 4, 2024Sep 5, 2024View →
HCAT
HEALTH CATALYST, INC.
SALE
Chief Operating Officer
1,761$7.27$12.8K148,245Sep 3, 2024Sep 5, 2024View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
5,209$6.19$32.2K150,006Aug 5, 2024Aug 7, 2024View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
5,208$6.15$32.0K155,215Jul 3, 2024Jul 8, 2024View →
HCAT
HEALTH CATALYST, INC.
SALE10b5-1
10b5-1 plan
11,923$6.72$80.1K160,423Jun 6, 2024Jun 12, 2024View →
HCAT
HEALTH CATALYST, INC.
SALE
Chief Operating Officer
1,873$6.53$12.2K172,346Jun 3, 2024Jun 4, 2024View →
HCAT
HEALTH CATALYST, INC.
SALE
Chief Operating Officer
3,279$8.05$26.4K104,219Mar 1, 2024Mar 5, 2024View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
70,000174,219Mar 1, 2024Mar 5, 2024View →
Other insiders · HCAT
Loading peer insiders…
About this filer
CIK 0002013388
ROLE
Chief Operating Officer
PRIMARY
HCAT
COMPANIES
1
ACTIVE SINCE
Mar 2024
MARKETPEEL · /INSIDER/0002013388DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback